HCMG
Howard Capital Management Group’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219K | Sell |
2,640
-865
| -25% | -$71.7K | 0.02% | 117 |
|
|
2025
Q1 | $284K | Sell |
3,505
-250,661
| -99% | -$20.3M | 0.02% | 105 |
|
|
2024
Q4 | $22.9M | Buy |
254,166
+6,052
| +2% | +$545K | 1.57% | 28 |
|
|
2024
Q3 | $24.5M | Buy |
248,114
+6,188
| +3% | +$611K | 1.72% | 28 |
|
|
2024
Q2 | $22.4M | Buy |
241,926
+12,271
| +5% | +$1.14M | 1.65% | 25 |
|
|
2024
Q1 | $21.8M | Buy |
229,655
+5,431
| +2% | +$515K | 1.68% | 25 |
|
|
2023
Q4 | $20M | Buy |
224,224
+7,365
| +3% | +$658K | 1.74% | 25 |
|
|
2023
Q3 | $15.8M | Buy |
216,859
+7,431
| +4% | +$543K | 1.53% | 29 |
|
|
2023
Q2 | $17.4M | Buy |
209,428
+5,134
| +3% | +$427K | 1.62% | 28 |
|
|
2023
Q1 | $15.6M | Sell |
204,294
-1,292
| -0.6% | -$98.5K | 1.65% | 28 |
|
|
2022
Q4 | $17.1M | Buy |
205,586
+1,619
| +0.8% | +$134K | 2.05% | 24 |
|
|
2022
Q3 | $16.2M | Sell |
203,967
-77
| -0% | -$6.11K | 2.04% | 24 |
|
|
2022
Q2 | $15.2M | Buy |
204,044
+5,086
| +3% | +$378K | 1.78% | 27 |
|
|
2022
Q1 | $17.9M | Buy |
198,958
+5,724
| +3% | +$514K | 1.63% | 29 |
|
|
2021
Q4 | $21.6M | Buy |
193,234
+7,665
| +4% | +$858K | 1.79% | 27 |
|
|
2021
Q3 | $23.3M | Buy |
185,569
+7,465
| +4% | +$938K | 2.16% | 20 |
|
|
2021
Q2 | $24.1M | Buy |
178,104
+6,270
| +4% | +$849K | 2.27% | 19 |
|
|
2021
Q1 | $23.3M | Buy |
+171,834
| New | +$23.3M | 2.44% | 17 |
|